Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
62,327,754
-
Shares change
-
+9,594,058
-
Total reported value, excl. options
-
$271,618,599
-
Value change
-
+$56,872,305
-
Put/Call ratio
-
241%
-
Number of buys
-
83
-
Number of sells
-
-40
-
Price
-
$4.36
Significant Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q2 2018
156 filings reported holding TRXC - TRANSENTERIX INC - COM NEW as of Q2 2018.
TRANSENTERIX INC - COM NEW (TRXC) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62,327,754 shares
.
Largest 10 shareholders include BlackRock Inc. (9,870,565 shares), SV Health Investors, LLC (7,546,692 shares), VANGUARD GROUP INC (7,451,965 shares), JPMORGAN CHASE & CO (6,984,809 shares), Aisling Capital LLC (6,389,352 shares), STATE STREET CORP (3,294,763 shares), Global X Management Co LLC (2,571,476 shares), Artemis Investment Management LLP (1,315,072 shares), MASTERS CAPITAL MANAGEMENT LLC (1,236,505 shares), and ROYAL BANK OF CANADA (1,231,762 shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.